Australia markets closed

Cellebrite DI Ltd. (CLBTW)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
2.6900+0.0100 (+0.37%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
343,458
325,110
270,651
246,246
194,913
Cost of revenue
54,089
53,231
50,746
42,557
37,879
Gross profit
289,369
271,879
219,905
203,689
157,034
Operating expenses
Research development
86,452
84,386
80,620
65,541
54,377
Selling general and administrative
160,569
154,256
138,241
124,326
93,439
Total operating expenses
247,021
238,642
218,861
189,867
147,816
Operating income or loss
42,348
33,237
1,044
13,822
9,218
Interest expense
39,942
141
149
153
0
Total other income/expenses net
-
206
845
-194
-446
Income before tax
-106,253
-75,563
120,760
82,305
11,397
Income tax expense
5,614
5,537
-45
10,909
5,616
Income from continuing operations
-111,867
-81,100
120,805
71,396
5,781
Net income
-111,867
-81,100
120,805
71,396
5,781
Net income available to common shareholders
-111,867
-81,100
116,111
70,433
-9,344